Phase 2 Study of WGI-0301 for Advanced HCC
Phase 2 Study of WGI-0301 for Advanced HCC
Recruiting · NCT06309485 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of WGI-0301 for Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | Phase 2 | 2026-09-11 | NCT06309485 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Haichang Biotech Co., Ltd. | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Pharmaceutical University, Shanghai Gobroad Cancer Hospital | Shanghai | China | 2 |
| Harbin Medical University Cancer Hospital | Harbin | China | 35 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Jiangxi Cancer Hospital | Nanchang | China | 18 |
| Prince of Wales Hospital | Hong Kong | Hong Kong | 81 |
| Sir Run Run Shaw Hospital Zhejiang University School of Medicine | Hangzhou | China | 5 |
| Tongji Hospital Tongji Medical College of HUST | Wuhan | China | 4 |
| West China Hospital Sichuan University | Chengdu | China | 5 |
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |